ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer.

Anna Spreafico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.